Nyxoah

Company Profile

Nyxoah had its IPO on 2021-07-02 under the ticker symbol NYXH.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Nyxoah has a staff strength of 137 employees.

Stock update

Shares of Nyxoah opened at $8.21 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $8.21 - $8.21, and closed at $8.21.

This is a 0% increase from the previous day's closing price.

A total volume of 273 shares were traded at the close of the day’s session.

In the last one week, shares of Nyxoah have increased by +9.39%.

Nyxoah's Key Ratios

Nyxoah has a market cap of $222.51 million, indicating a price to book ratio of 1.0697 and a price to sales ratio of 73.8386.

In the last 12-months Nyxoah’s revenue was $3.04 million with a gross profit of $1.93 million and an EBITDA of $-40600000. The EBITDA ratio measures Nyxoah's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nyxoah’s operating margin was -1353.51% while its return on assets stood at -16.61% with a return of equity of -34.86%.

In Q2, Nyxoah’s quarterly earnings growth was a positive 0% while revenue growth was a positive 18.3%.

Nyxoah’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.74 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nyxoah’s profitability.

Nyxoah stock is trading at a EV to sales ratio of 20.2416 and a EV to EBITDA ratio of -2.2162. Its price to sales ratio in the trailing 12-months stood at 73.8386.

Nyxoah stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$142.41 million

Total Liabilities

$15.24 million

Operating Cash Flow

$0

Capital Expenditure

$2.53 million

Dividend Payout Ratio

0%

Nyxoah ended 2024 with $142.41 million in total assets and $0 in total liabilities. Its intangible assets were valued at $142.41 million while shareholder equity stood at $115.58 million.

Nyxoah ended 2024 with $0 in deferred long-term liabilities, $15.24 million in other current liabilities, 4924000.00 in common stock, $-142522000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $16.60 million and cash and short-term investments were $84.52 million. The company’s total short-term debt was $1,310,000 while long-term debt stood at $8.43 million.

Nyxoah’s total current assets stands at $91.33 million while long-term investments were $0 and short-term investments were $67.92 million. Its net receivables were $4.08 million compared to accounts payable of $2.66 million and inventory worth $1.15 million.

In 2024, Nyxoah's operating cash flow was $0 while its capital expenditure stood at $2.53 million.

Comparatively, Nyxoah paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$8.21

52-Week High

$10.34

52-Week Low

$4.36

Analyst Target Price

$12.53

Nyxoah stock is currently trading at $8.21 per share. It touched a 52-week high of $10.34 and a 52-week low of $10.34. Analysts tracking the stock have a 12-month average target price of $12.53.

Its 50-day moving average was $7.92 and 200-day moving average was $6.93 The short ratio stood at 28.32 indicating a short percent outstanding of 0%.

Around 4563% of the company’s stock are held by insiders while 2512.5% are held by institutions.